-
eidospp15 ha inviato un aggiornamento 2 anni, 7 mesi fa
In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. Within the industry itself, of course, we understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”
At Tedor Pharma, we may be leaders in pharmaceutical formulation for our clients, but we also want to be understandable to laypeople and the rest of the public. The world of solid-dose production can indeed be quite technical and involved, but it means nothing if our work is so opaque as to be confusing.
In that case, we will be using this article to discuss the difference between FDF and API and how these two pieces of the pharmaceutical formulation process are interrelated.
WHAT IS AN FDF?
As stated previously, FDF stands for Finished Dosage Form, and it refers to the actual finalized drug product that is meant for consumption. FDFs can take a variety of forms, including solid tablets or capsules, a liquid solution, or another type. FDFs usually contain an API alongside various inactive ingredients.
In this case, then, the next time you see “FDF” in reference to pharmaceuticals, you will know the term simply refers to the physical form of the drug that was produced for sale at any pharmacy where customers shop.
